Zopiclone R-Isomer
CAS: 138680-08-7
Ref. 3D-NFA68008
| 1g | Discontinued | ||
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
- 1-Piperazinecarboxylic acid, 4-methyl-, (5R)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester (9CI)
- 1-Piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester, (R)-
- 5H-Pyrrolo[3,4-b]pyrazine, 1-piperazinecarboxylic acid deriv
- 4-methyl-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester-1-Piperazinecarboxylic acid
Zopiclone R-isomer is a benzodiazepine with hypnotic properties. It binds to the benzodiazepine receptor and acts on the GABA-A receptor, which has been implicated in the pathophysiology of anxiety and insomnia. Zopiclone R-isomer is an enantiopure drug, which means that it is composed of one enantiomer. This drug has been shown to be effective for the treatment of insomnia, although it may have some adverse effects such as drowsiness, dizziness, and impaired coordination. The potential impurities that may be present in this product are benzoic acid (B), malonic acid (M), and diazepam (D). These impurities can be determined by gas chromatography/mass spectrometry or infrared spectroscopy. The binding reactions of zopiclone R-isomer were studied using receptor binding experiments on calf thymus DNA and bacterial DNA gyrase. Molecular modelling was
